The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists

Ophthalmology

Volumn 106, Issue 11, 1999, Pages 2047-2053

  Trobe, Jonathan D ^a,c   Sieving, Pamela C ^a   Guire, Kenneth E ^b   Mark Fendrick, A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PREDNISONE;

ARTICLE; HUMAN; MEDICAL LITERATURE; MEDICAL PRACTICE; NEUROLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOLOGY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT PLANNING;

EID: 0033505184     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90482-7     Document Type: Article

References (24)

1. Fineberg HV. Clinical evaluation: how does it influence medical practice? Bull Cancer 1987;74:333-46.
2. Garnier HS, Flamant R, Fohanno C. Assessment of the role of randomized clinical trials in establishing treatment policies. Controlled Clin Trials 1982;3:227-34.
3. Gurwitz JH, Goldberg RJ, Chen Z, et al. Beta blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med 1992;93:605-10.
4. Lamas GA, Pfeffer MA, Hamm P, et al. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. N Engl J Med 1992;327:241-7.
5. Ayanian JZ, Hauptman PJ, Gaudagnoli E, et al. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med 1994;331:1136-42.
6. Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992;326:581-8.
7. Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med 1993;329:1764-9.
8. Beck RW, Trobe JD. What we have learned from the Optic Neuritis Treatment Trial. Ophthalmology 1995;102:1504-8.
9. Beck RW, Trobe JD. The Optic Neuritis Treatment Trial. Putting the results in perspective. The Optic Neuritis Study Group. J Neuroophthalmol 1995;15:131-5.
10. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol 1991;109:1673-8.
11. Lessell S. Corticosteroid treatment of acute optic neuritis [editorial]. N Engl J Med 1992;326:634-5.
12. Silberberg DH. Corticosteroids and optic neuritis [editorial]. N Engl J Med 1993;329:1808-10.
13. Beck RW, Cleary PA. Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol 1993;111:773-5.
14. Beck RW. The Optic Neuritis Treatment Trial. Implications for clinical practice [editorial]. Optic Neuritis Study Group. Arch Ophthalmol 1992;110:331-2.
15. Trobe JD. High-dose corticosteroid regimen retards development of multiple sclerosis in Optic Neuritis Treatment Trial [editorial]. Arch Ophthalmol 1994;112:35-6.
16. Savino PJ. Optic Neuritis Treatment Trial [editorial]. J Neuroophthalmol 1994;14:55-7.
17. Trobe JD. Managing optic neuritis: results of the Optic Neuritis Treatment Trial. Focal Points 1994;12(2).
18. Kupersmith MJ, Kaufman D, Paty DW, et al. Megadose corticosteroids in multiple sclerosis [editorial]. Neurology 1994;44:1-4.
19. Beck RW. Corticosteroid treatment of optic neuritis: a need to change treatment practices. The Optic Neuritis Study Group [editorial]. Neurology 1992;42:1133-5.
20. Chrousos GA, Kattah JC, Beck RW, Cleary PA. Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial. JAMA 1993;269:2110-2.
21. Greer AL. The state of the art versus the state of the science. The diffusion of new medical technologies into practice. Int J Technol Assess Health Care 1988;4:5-26.
22. Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med 1993;329:1271-3.
23. Kosecoff J, Kanouse DE, Rogers WH, et al. Effects of the National Institutes of Health Consensus Development Program on physician practice. JAMA 1987;258:2708-13.
24. Tunis SR, Hayward RSA, Wilson MC, et al. Internists' attitudes about clinical practice guidelines. Ann Intern Med 1994; 120:956-63.